Approaches to neuromodulation for schizophrenia
نویسندگان
چکیده
منابع مشابه
Approaches to neuromodulation for schizophrenia.
Based on the success of deep brain stimulation (DBS) for treating movement disorders, there is growing interest in using DBS to treat schizophrenia (SZ). We review the unmet needs of patients with SZ and the scientific rationale behind the DBS targets proposed in the literature in order to guide future development of DBS to treat this vulnerable patient population. SZ remains a devastating diso...
متن کاملCircuits and Circuit Disorders: Approaches to Neuromodulation.
Thisthemeissueon“CircuitsandCircuitDisorders:Approaches to Neuromodulation” is the result of a symposium held at the annual meeting of the American Neurological Association in Chicago, Illinois, on September 26, 2015, and cosponsored by JAMA Neurology and the Annals of Neurology. The speakers wereMahlonDeLong,MD,EmoryUniversity (KeynoteSpeaker), Philip Starr, MD, University of California, San F...
متن کاملPersonalised approaches to pharmacotherapy for schizophrenia
Personalised medicine has been defined as the ‘use of genetic or other biomarker information to improve the safety, effectiveness, and health outcomes of patients via more efficiently targeted risk strati fication, prevention, and tailored medication and treatment management approaches’ (Faulkner 2012). It is a novel approach to therapeutic decisionmaking, which has particular relevance and pot...
متن کاملBayesian inference, dysconnectivity and neuromodulation in schizophrenia.
Heinemann U, et al. Nitric oxide modulates spreading depolarization threshold in the human and rodent cortex. Delayed inflammation in rat meninges: implications for migraine pathophysiology. lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihy-droergotamine during glyceryl trinitrate-induced migraine. Brain 2016, in press. This scientific commentary ref...
متن کاملpharmacotherapy of schizophrenia: ploypharmacy approaches
schizophrenia is a debilitating illness, rating as one of the leading causes of lost years of quality of life. the illness imposes a disproportionate burden on patients and their families, healthcare systems and society. pharmacological management is the cornerstone of treatment of schizophrenia, and antipsychotics, both first generation of antipsychotics and second generation of antipsychotics...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 2017
ISSN: 0022-3050,1468-330X
DOI: 10.1136/jnnp-2017-316946